San Francisco, United States
Yosemite
$350.0M
startup
Summary
Yosemite announced the first close of its second fund earlier in the year, targeting $350 million. The firm says it focuses exclusively on oncology and uses a mix of philanthropy and venture capital to build biotech companies from scratch.
Investors
Unknown investors